A companion diagnostic device is a special type of invitro medical device that provides information, which is necessary for the effective and safe use of an analogous drug or biological product. Companion diagnostics are developed simultaneously with drugs to help include or exclude a certain group of patients for treatment with a particular drug based on their biological characteristics, which determines patients who respond and those who dont respond to the therapy.

Market Analysis and Insights: Global Companion Diagnostic Market
The global Companion Diagnostic market size is projected to reach US$ 10700 million by 2026, from US$ 8820 million in 2020, at a CAGR of 20.3%% during 2021-2026.

Global Companion Diagnostic Scope and Market Size
Companion Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study

Abbott Laboratories
Agilent Technologies
Danaher
Illumina
Myriad Genetics
Qiagen
Roche
Thermo Fisher Scientific
Sysmex
Novartis

Market segment by Type, the product can be split into

Assay Kits
Reagents

Market segment by Application, split into

Pharmaceutical & Biopharmaceutical Companies
Laboratories
Other

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India